Abiopharma

🔍 Dorsey Mark (Executive)

Company: APPIAN CORP (APPN)

Report Date: 2025-08-20

Detailed Transactions and Holdings:

• Acquired 18,132 shares of Restricted Stock Unit (Derivative)
  Date: 2025-08-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 18,132.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock (or its cash equivalent, at the discretion of the Issuer).
• F2: The RSUs were granted on August 20, 2025, and vest in four (4) equal annual installments commencing on August 5, 2026, provided that the Reporting Person has provided continuous service to the Issuer through each vesting date.